Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies

mRNA based vaccines against COVID-19 have proven most successful at keeping SARS-CoV-2 pandemic at bay in many countries. Recently, there is an increased interest in heterologous prime-boost vaccination strategies for COVID-19 to maintain antibody responses for the control of continuously emerging S...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Anne-Cathrine S. Vogt, Lukas Jörg, Byron Martina, Pascal S. Krenger, Xinyue Chang, Andris Zeltins, Monique Vogel, Mona O. Mohsen, Martin F. Bachmann
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2022-06-01
主題:	SARS-CoV-2 vaccine virus-like particles mRNA COVID-19
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.864718/full